RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Axim Biotechnologies Stock

Axim Biotechnologies P/S 2024

Axim Biotechnologies P/S

130.78

Ticker

AXIM

ISIN

US05463V1008

WKN

A2DF26

As of Dec 20, 2024, Axim Biotechnologies's P/S ratio stood at 130.78, a -86.6% change from the 976.27 P/S ratio recorded in the previous year.

The Axim Biotechnologies P/S history

Axim Biotechnologies Aktienanalyse

What does Axim Biotechnologies do?

Axim Biotechnologies Inc is an innovative biotechnology company focusing on the research, development, and marketing of pharmaceutical products, medical devices, and diagnostic tests based on cannabis. The company is headquartered in New York City and has become one of the leading companies in the industry since its founding in 2014. Axim Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Axim Biotechnologies's P/S Ratio

Axim Biotechnologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Axim Biotechnologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Axim Biotechnologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Axim Biotechnologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Axim Biotechnologies stock

What is the price-to-earnings ratio of Axim Biotechnologies?

The price-earnings ratio of Axim Biotechnologies is currently 130.78.

How has the price-earnings ratio of Axim Biotechnologies changed compared to last year?

The price-to-earnings ratio of Axim Biotechnologies has increased by -86.6% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Axim Biotechnologies high compared to other companies?

Yes, the price-to-earnings ratio of Axim Biotechnologies is high compared to other companies.

How does an increase in the price-earnings ratio of Axim Biotechnologies affect the company?

An increase in the price-earnings ratio of Axim Biotechnologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Axim Biotechnologies affect the company?

A decrease in the price-earnings ratio of Axim Biotechnologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Axim Biotechnologies?

Some factors that influence the price-earnings ratio of Axim Biotechnologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Axim Biotechnologies pay?

Over the past 12 months, Axim Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Axim Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Axim Biotechnologies?

The current dividend yield of Axim Biotechnologies is .

When does Axim Biotechnologies pay dividends?

Axim Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Axim Biotechnologies?

Axim Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Axim Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Axim Biotechnologies located?

Axim Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Axim Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Axim Biotechnologies from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Axim Biotechnologies pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Axim Biotechnologies in the year 2023?

In the year 2023, Axim Biotechnologies distributed 0 USD as dividends.

In which currency does Axim Biotechnologies pay out the dividend?

The dividends of Axim Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Axim Biotechnologies

Our stock analysis for Axim Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Axim Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.